| AD | Alzheimer’s disease |
| CRCI | Cancer-related cognitive impairment |
| CMF | Cyclophosphamide, methotrexate, and fluorouracil |
| PD | Parkinson’s disease |
| SES | Socioeconomic status |
| AD | Alzheimer’s disease |
| CRCI | Cancer-related cognitive impairment |
| CMF | Cyclophosphamide, methotrexate, and fluorouracil |
| PD | Parkinson’s disease |
| SES | Socioeconomic status |